CADTH endorses that public drug strategies reimburse Hemgenix with the treatment of hemophilia B if specified conditions are achieved. When given for the affected individual, the virus will carry the factor IX gene to the liver cells, enabling them to create the lacking factor IX and thereby limit bleeding episodes. https://libmeldy27260.webbuzzfeed.com/36470332/about-hemgenix